InterCure Ltd.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $9.8M
- Price
- $4.47
- % Change (Daily % change from the live per-ticker quote feed.)
- +4.68%
- Volume
- 1.8K
About
InterCure Ltd., including its subsidiaries, is actively involved in the entire lifecycle of medical cannabis products. This encompasses everything from initial research and cultivation to manufacturing, marketing, and global distribution, serving both the Israeli market and international territories. The company's offerings feature dried cannabis flower alongside cannabis extracts infused with oil. Beyond its core cannabis operations, InterCure also directs investments towards the biomedical sector. Founded in 1994, the firm's main offices are located in Herzliya, Israel.
Quick stats
Shares outstanding2.2M
Computed float6.8M
Float / shares312.5%
Key info
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001857030
Websitehttps://www.intercure.co
AI Summary
AI-generated1/13
standardbullishother
InterCure Regains Compliance with Nasdaq Minimum Bid Price Requirement
InterCure has regained compliance with Nasdaq's minimum bid price requirement after its shares closed above $1.00 for 10 consecutive business days.
The company received a delisting notice on September 1, 2026, but successfully met the 180-day compliance period by August 24, 2026, and the subsequent 10-day confirmation period ending September 4, 2026.
This resolution closes the delisting matter and maintains the company's listing on The Nasdaq Global Market.